Three unrelated children from ethnically diverse backgrounds who were treated for acute leukaemia became profoundly and irreversibly deaf during treatment. Aminoglycoside levels were within the therapeutic range. Genetic testing showed all three to have a maternally inherited mutation of mitochondrial DNA, m.1555A>G, known to cause sensitivity to the ototoxic effects of aminoglycosides. One child has received a cochlear implant, and another will be implanted shortly. Children diagnosed with acute leukaemia should be tested for this mutation at diagnosis, and alternative antibiotics chosen for the treatment of sepsis. Consideration should be given to elective testing of other groups of patients likely to receive aminoglycosides.

Download full-text PDF

Source
http://dx.doi.org/10.1136/adc.2009.158220DOI Listing

Publication Analysis

Top Keywords

acute leukaemia
12
aminoglycoside-induced deafness
4
deafness treatment
4
treatment acute
4
leukaemia three
4
three unrelated
4
unrelated children
4
children ethnically
4
ethnically diverse
4
diverse backgrounds
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!